total
fecal
sampl
cpv
isol
obtain
dog
diarrhea
itali
n
germani
n
unit
kingdom
n
portug
n
belgium
n
spain
n
switzerland
n
czech
republ
n
fecal
sampl
collect
itali
unit
kingdom
portug
belgium
cpvposit
accord
pcr
perform
local
laboratori
sampl
collect
except
sampl
itali
collect
studi
assess
molecular
epidemiolog
cpv
previou
decad
sampl
germani
consist
cpv
strain
isol
dog
diarrhea
germani
sampl
homogen
wv
phosphatebuff
salin
ph
subsequ
clarifi
centrifug
g
min
viral
dna
extract
supernat
fecal
homogen
viral
suspens
boil
min
chill
ice
reduc
residu
inhibitor
dna
polymeras
activ
ineffect
concentr
dna
extract
dilut
distil
water
cpv
dna
titer
calcul
use
realtim
pcr
base
taqman
technolog
abl
recogn
cpv
strain
wherea
character
viral
type
obtain
mean
mgb
probe
assay
specif
type
rule
presenc
cpv
strain
vaccin
origin
usual
type
less
frequent
type
subsequ
test
sampl
recogn
type
mgb
probe
assay
discrimin
vaccin
field
strain
cpv
sampl
cpvposit
result
laboratori
locat
countri
sampl
origin
confirm
taqman
assay
contain
cpv
dna
cpv
infect
also
demonstr
singl
sampl
spain
switzerland
czech
republ
figur
itali
nearli
complet
substitut
note
strain
found
low
frequenc
confirm
progress
decreas
note
past
year
contrast
still
preval
germani
portug
although
also
widespread
countri
retrospect
analysi
archiv
sampl
show
circul
germani
sinc
equival
distribut
type
assess
unit
kingdom
singl
strain
detect
portug
strain
detect
wherea
belgium
cpv
type
singl
sampl
switzerland
czech
republ
wherea
sampl
spain
origin
type
detect
sampl
unit
kingdom
itali
latter
sampl
collect
dog
shortli
vaccin
classic
vaccin
despit
dna
genom
cpv
possess
high
genet
substitut
rate
similar
observ
rna
virus
respons
continu
antigen
evolut
rapid
displac
old
type
new
antigen
variant
emerg
itali
spread
high
effici
dog
popul
itali
progress
replac
antigen
variant
variant
detect
vietnam
also
inform
avail
presenc
distribut
european
countri
except
singl
case
report
spain
studi
show
new
variant
widespread
european
countri
itali
portug
germani
could
detect
sporad
unit
kingdom
contrast
previou
studi
europ
studi
show
frequent
belgium
wherea
unit
kingdom
germani
itali
overtaken
portug
detect
type
equal
distribut
knowledg
first
report
new
variant
portug
unit
kingdom
germani
germani
detect
archiv
sampl
collect
thu
circul
europ
year
first
offici
report
itali
variabl
geograph
distribut
cpv
variant
europ
may
relat
differ
commerci
flow
dog
import
foreign
countri
rather
differ
vaccin
protocol
progress
spread
world
less
probabl
independ
emerg
differ
countri
suggest
mutat
provid
certain
advantag
viral
replic
replac
type
associ
increas
abil
bind
canin
transferrin
receptor
although
might
rule
possibl
mutat
residu
protein
select
also
antigen
effect
whether
mutat
confer
benefit
receptorbind
activ
interest
anoth
question
whether
cpv
vaccin
current
use
provid
full
protect
new
variant
whether
replac
homolog
vaccin
